Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NFATC2 |
| Upstream (Parents) |
|---|
| (<<) IKZF1 → NFATC2 |
| (<<) IRF1 → NFATC2 |
| (<<) SP140 → NFATC2 |
| (<<) FLI1 → NFATC2 |
| (<<) IRF8 → NFATC2 |
| (<<) HCLS1 → NFATC2 |
| (<<) STAT4 → NFATC2 |
| (<<) NR3C1 → NFATC2 |
| (<<) STAT2 → NFATC2 |
| Downstream (Children) |
|---|
| NFATC2 → EOMES (>>) |
| NFATC2 → BCL11B (>>) |
| NFATC2 → SCML1 (>>) |
| NFATC2 → DLX2 (>>) |
| NFATC2 → SLC30A9 (>>) |
| NFATC2 → BTG2 (>>) |
| NFATC2 → TRERF1 (>>) |
| NFATC2 → SATB1 (>>) |
| NFATC2 → EGR2 (>>) |
| NFATC2 → BACH2 (>>) |
| NFATC2 → LEF1 (>>) |
| NFATC2 → ZIC3 (>>) |
| NFATC2 → CREBL2 (>>) |
| NFATC2 → KDM5B (>>) |
| NFATC2 → GCFC1 (>>) |
| NFATC2 → HSF5 (>>) |
| NFATC2 → TFEB (>>) |
